The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: A second type of “autoimmune” hepatitis
Open accessAbstract
Sixty-five patients with histologically proven chronic active hepatitis of unknown cause but associated with the antiliver/kidney microsome antibody type 1, confirmed by immunofluorescence and immunoprecipitation, were selected as forming a special entity. This disease was found to be rare with a prevalence of 5/1,000,000. The female to male ratio was 8:1. The condition occurred at all ages but was most common between the ages of 2 and 14 years. In 22 of the 65 cases, the hepatitis was associated with an autoimmune disease, most commonly insulin-dependent diabetes, autoimmune thyroid disease and vitiligo. The same autoimmune diseases were present in first-degree relatives from seven families. In 36 cases, the onset of disease resembled acute viral hepatitis. Serum biochemical tests showed marked elevation in aminotransaminases and hypergammaglobulinemia. Paradoxically, serum and salivary IgA levels were often normal or low. Histologic findings were multifocal hepatic necrosis with bridging in the acute stage, and aggressive hepatitis with mono-nuclear cell infiltration or macronodular cirrhosis in the late stages. Serologically, apart from the presence of antiliver/kidney microsome antibody type 1, the disease was characterized by the absence of antiactin, antimitochondria and antinucleus antibodies; however, organ-specific autoantibodies were often present. The clinical course was usually severe: six patients in the acute stage presented with fulminant hepatitis, and all, except two, other patients progressed to cirrhosis, Prolonged treatment with corticosteroids and immunosuppressants was usually effective in rendering the cirrhosis inactive. The cumulative survival rate was 51% at 14 years.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue fractionation studies. 6. Intracellular distribution patterns of enzymes in rat-liver tissue
de Duve, C., Pressman, B. C., Gianetto, R., Wattiaux, R., & Appelmans, F. (1955) · Biochemical Journal · doi:10.1042/bj0600604 · Cited by 4,174
Diseases of the Liver and Biliary System
(2001) · Wiley eBooks · doi:10.1002/9780470986820 · Cited by 1,825
Autoimmune Polyglandular Syndromes
Neufeld, M., MacLaren, N., & Blizzard, R. (1980) · Pediatric Annals · doi:10.3928/0090-4481-19800401-07 · Cited by 471
Mackay, I., Taft, L. I., & Cowling, D. C. (1956) · The Lancet · doi:10.1016/s0140-6736(56)91483-0 · Cited by 362
Gabbiani, G., Ryan, G. B., Lamelin, J. P., VASSALLI, P., Majno, G., Bouvier, C. A., Cruchaud, A., & Lüscher, E. F. (1973) · PubMed Central · Cited by 258
Microsomal antibodies in active chronic hepatitis and other disorders.
Rizzetto, M., Swana, G. T., & Doniach, D. (1973) · PubMed · Cited by 248
A new anti-liver-kidney microsome antibody (anti-LKM2) in tienilic acid-induced hepatitis.
Homberg, J., Andre, C., & Abuaf, N. (1984) · PubMed · Cited by 165
Self-citationSmooth muscle autoantibodies and autoantigens.
Bh, T. (1979) · PubMed Central · Cited by 146
Microsomal autoantibodies in chronic infection with the HBsAg associated delta (delta) agent.
Crivelli, O., Lavarini, C., Chiaberge, E., Amoroso, A., Farci, P., Negro, F., & Rizzetto, M. (1983) · PubMed Central · Cited by 143
Smooth Muscle Autoantibody in “Autoimmune” Hepatitis
Whittingham, S., Irwin, J., Mackay, I. R., & Smalley, M. (1966) · Gastroenterology · doi:10.1016/s0016-5085(19)34365-3 · Cited by 119
Cited by
Classification of chronic hepatitis: Diagnosis, grading and staging
Desmet, V. J., Gerber, M., Hoofnagle, J. H., Manns, M., & Scheuer, P. J. (1994) · Hepatology · doi:10.1002/hep.1840190629 · Cited by 2,593
Epidemiology and estimated population burden of selected autoimmune diseases in the United States
Jacobson, D. L., Gange, S. J., Rose, N. R., & Graham, N. M. H. (1997) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1997.4412 · Cited by 1,667
Human UDP-Glucuronosyltransferases: Metabolism, Expression, and Disease
Tukey, R. H., & Strassburg, C. P. (2000) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.581 · Cited by 1,523
Meeting report: International autoimmune hepatitis group
Johnson, P. J., & McFarlane, I. G. (1993) · Hepatology · doi:10.1002/hep.1840180435 · Cited by 1,090
Mack, C. L., Adams, D., Assis, D. N., Kerkar, N., Manns, M. P., Mayo, M. J., Vierling, J. M., Alsawas, M., Murad, M. H., & Czaja, A. J. (2020) · Hepatology · doi:10.1002/hep.31065 · Cited by 983
“(149) Autoimmune thyroid disease has been the most common concurrent autoimmune disease in type 1 AIH (10%-18%),(129,150-152) whereas type 1 diabetes,(153) autoimmune thyroid disease,(153) and autoimmune skin diseases (vitiligo, leucocytoclastic vasculitis, urticaria, alopecia areata) have been most common in type 2 A…”
BackgroundInfluentialAutoimmune Hepatitis in Childhood: A 20–Year Experience
Gregorio, G. V., Portmann, B., Reid, F., Donaldson, P. T., Doherty, D. G., McCartney, M., Mowat, A. P., Vergani, D., & Mieli-Vergani, G. (1997) · Hepatology · doi:10.1002/hep.510250308 · Cited by 665
Diagnosis and treatment of autoimmune hepatitis
Czaja, A. J., & Freese, D. K. (2002) · Hepatology · doi:10.1053/jhep.2002.34944 · Cited by 563
Lapierre, P., Hajoui, O., Homberg, J.-C., & Alvarez, F. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70186-1 · Cited by 538
Self-citationVergani, D., Alvarez, F., Bianchi, F. B., Cançado, E. L. R., Mackay, I. R., Manns, M. P., Nishioka, M., & Penner, E. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.08.002 · Cited by 446
Mieli-Vergani, G., Vergani, D., Czaja, A. J., Manns, M. P., Krawitt, E. L., Vierling, J. M., Lohse, A. W., & Montano-Loza, A. J. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.17 · Cited by 425
Impairment of CD4+CD25+ regulatory T-cells in autoimmune liver disease
Longhi, M. S., Ma, Y., Bogdanos, D. P., Cheeseman, P., Mieli-Vergani, G., & Vergani, D. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.03.008 · Cited by 405
Manns, M. P., Johnson, E. F., Griffin, K. J., Tan, E. M., & Sullivan, K. F. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113949 · Cited by 363
High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C†
Clifford, B. D., Donahue, D., Smith, L., Cable, E., Luttig, B., Manns, M., & Bonkovsky, H. L. (1995) · Hepatology · doi:10.1002/hep.1840210302 · Cited by 354
Advances in the Diagnosis, Pathogenesis, and Management of Autoimmune Hepatitis
Czaja, A. J., & Manns, M. P. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.04.053 · Cited by 280
Heneghan, M. A., Yeoman, A. D., Verma, S., Smith, A. D., & Longhi, M. S. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62163-1 · Cited by 277
Hasler, J. A., Estabrook, R., Murray, M., Pikuleva, I., Waterman, M., Capdevila, J., Holla, V., Helvig, C., Falck, J. R., Farrell, G., et al. (1999) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(99)00005-9 · Cited by 267
Larrey, D. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80417-1 · Cited by 253
Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis
Cookson, S., Constantini, P. K., Clare, M., Underhill, J. A., Bernal, W., Czaja, A. J., & Donaldson, P. T. (1999) · Hepatology · doi:10.1002/hep.510300412 · Cited by 180
Prediction of short- and long-term outcome in patients with autoimmune hepatitis
Kirstein, M. M., Metzler, F., Geiger, E., Heinrich, E., Hallensleben, M., Manns, M. P., & Vogel, A. (2015) · Hepatology · doi:10.1002/hep.27983 · Cited by 136
Interpreting serological tests in diagnosing autoimmune liver diseases
Invernizzi, P., Lleo, A., & Podda, M. (2007) · Seminars in Liver Disease · doi:10.1055/s-2007-979469 · Cited by 107
Autoimmune hepatitis and its variant syndromes
BEN-ARI, Z., & CZAJA, A. J. (2001) · Gut · doi:10.1136/gut.49.4.589 · Cited by 102
Terziroli Beretta-Piccoli, B., Mieli-Vergani, G., & Vergani, D. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.10.004 · Cited by 61
“Autoimmune(-Like)” drug and herb induced liver injury: new insights into molecular pathogenesis
Sebode, M., Schulz, L., & Lohse, A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091954 · Cited by 47
Metadata
- Authors
- Homberg, J.-C., Abuaf, N., Bernard, O., Islam, S., Alvarez, F., Khalil, S. H., Poupon, R., Darnis, F., Lévy, V.-G., Grippon, P., Opolon, P., Bernuau, J., Benhamou, J.-P., & Alagille, D.
- Venue
- Hepatology
- Published
- 1987-11
- Volume
- 7
- Issue
- 6
- Pages
- 1333-1339
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2017492932
- Cited by
- 576
- References
- 19
- FWCI
- 12.57
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.